{"id":3395,"date":"2020-01-16T07:26:08","date_gmt":"2020-01-16T07:26:08","guid":{"rendered":"https:\/\/cms.alj3.clients.lemonhq.io\/press-release\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/"},"modified":"2024-10-25T08:09:07","modified_gmt":"2024-10-25T08:09:07","slug":"abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6","status":"publish","type":"pressrelease","link":"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/","title":{"rendered":"Abdul Latif Jameel y Cellspect colaboran para llevar la pr\u00f3xima generaci\u00f3n de dispositivos port\u00e1tiles y de bajo coste para el an\u00e1lisis de la sangre en el punto de atenci\u00f3n a los mercados en desarrollo."},"content":{"rendered":"\n<ul class=\"wp-block-list\">\n<li>Aim to provide simple, accurate, affordable and rapid blood testing in developing countries.<\/li>\n\n\n\n<li>Next-generation PoCT (Point of Care Testing) device enabling multiple blood testing parameters to be performed simultaneously.<\/li>\n<\/ul>\n\n<p><a href=\"https:\/\/alj-japan.co.jp\/english\/japan\/\">Abdul Latif Jameel General Trading<\/a> based in Tokyo, Japan, part of the diversified family business <a href=\"https:\/\/alj.com\">Abdul Latif Jameel<\/a>, announced a new collaboration with <a href=\"https:\/\/cellspect.com\/en\/\">Cellspect<\/a> for the distribution of the Cellspect blood testing device in the Middle East, Africa, Southeast Asia and India.<\/p>\n\n<p>Cellspect, based in Japan, develops and produces next-generation PoCT (Point of Care Testing) devices that enable multiple blood testing parameters to be screened for simultaneously.\u00a0 \u00a0Basic biochemical tests such as \u2018sugar metabolism\u2019, \u2018lipid\u2019 and \u2018liver function\u2019 can be easily measured with just single a droplet of blood from the patient\u2019s finger, and the device itself, in a simple to use, compact and portable form for ease of deployment and use in remote areas and rural settings.<\/p>\n\n<p>This low-cost device provides results is less than 5 minutes, making it extremely rapid, cost-competitive, and accessible to populations in developing countries, compared to many existing PoCT devices.<\/p>\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">https:\/\/youtu.be\/RaydkfoEsPU<\/div><\/figure>\n<p>In addition to the existing blood testing parameters which have demonstrated very high accuracy levels, Cellspect also plans to add multiple other parameters in the near future including cardiac markers, cancer markers, viruses and allergies to name a few, with the aim to have more than 35 blood testing parameters in a single and simple to use device.<\/p>\n\n<p>In anticipation of continued international expansion, Cellspect will also be able to customize test parameters and targets to meet the immediate market needs of each country.<\/p>\n\n<p>Through this alliance, Abdul Latif Jameel General Trading and Cellspect aim to create accessible and affordable opportunities, particularly in developing regions, by providing blood-testing health checks to populations who may not have affordable or convenient access to healthcare facilities<\/p>\n\n<p>Abdul Latif Jameel believes that creating convenient, affordable, fast and accurate blood testing capability can greatly contribute to the improvement of medical infrastructure and personal healthcare in developing countries and assist efforts toward early detection and prevention of diseases.<\/p>\n\n<p>Through investment in Japan&#8217;s superior medical technologies and business support for developing Japan\u2019s innovative medical technologies in emerging countries, Abdul Latif Jameel General Trading strives to continue to make a meaningful social contribution.<\/p>\n","protected":false},"featured_media":3376,"menu_order":0,"template":"","class_list":["post-3395","pressrelease","type-pressrelease","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Abdul Latif Jameel y Cellspect colaboran para llevar la pr\u00f3xima generaci\u00f3n de dispositivos port\u00e1tiles y de bajo coste para el an\u00e1lisis de la sangre en el punto de atenci\u00f3n a los mercados en desarrollo. - Abdul Latif Jameel<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abdul Latif Jameel y Cellspect colaboran para llevar la pr\u00f3xima generaci\u00f3n de dispositivos port\u00e1tiles y de bajo coste para el an\u00e1lisis de la sangre en el punto de atenci\u00f3n a los mercados en desarrollo. - Abdul Latif Jameel\" \/>\n<meta property=\"og:description\" content=\"Abdul Latif Jameel General Trading based in Tokyo, Japan, part of the diversified family business Abdul Latif Jameel, announced a new collaboration with Cellspect for the distribution of the Cellspect blood testing device in the Middle East, Africa, Southeast Asia and India. Cellspect, based in Japan, develops and produces next-generation PoCT (Point of Care Testing) [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/\" \/>\n<meta property=\"og:site_name\" content=\"Abdul Latif Jameel\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-25T08:09:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Cellspect-signing.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1235\" \/>\n\t<meta property=\"og:image:height\" content=\"922\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/\",\"url\":\"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/\",\"name\":\"Abdul Latif Jameel y Cellspect colaboran para llevar la pr\u00f3xima generaci\u00f3n de dispositivos port\u00e1tiles y de bajo coste para el an\u00e1lisis de la sangre en el punto de atenci\u00f3n a los mercados en desarrollo. - Abdul Latif Jameel\",\"isPartOf\":{\"@id\":\"https:\/\/10.0.2.222\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Cellspect-signing.jpg\",\"datePublished\":\"2020-01-16T07:26:08+00:00\",\"dateModified\":\"2024-10-25T08:09:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/#primaryimage\",\"url\":\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Cellspect-signing.jpg\",\"contentUrl\":\"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Cellspect-signing.jpg\",\"width\":1235,\"height\":922},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/10.0.2.222\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abdul Latif Jameel y Cellspect colaboran para llevar la pr\u00f3xima generaci\u00f3n de dispositivos port\u00e1tiles y de bajo coste para el an\u00e1lisis de la sangre en el punto de atenci\u00f3n a los mercados en desarrollo.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/10.0.2.222\/en\/#website\",\"url\":\"https:\/\/10.0.2.222\/en\/\",\"name\":\"Abdul Latif Jameel\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/10.0.2.222\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abdul Latif Jameel y Cellspect colaboran para llevar la pr\u00f3xima generaci\u00f3n de dispositivos port\u00e1tiles y de bajo coste para el an\u00e1lisis de la sangre en el punto de atenci\u00f3n a los mercados en desarrollo. - Abdul Latif Jameel","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"es_ES","og_type":"article","og_title":"Abdul Latif Jameel y Cellspect colaboran para llevar la pr\u00f3xima generaci\u00f3n de dispositivos port\u00e1tiles y de bajo coste para el an\u00e1lisis de la sangre en el punto de atenci\u00f3n a los mercados en desarrollo. - Abdul Latif Jameel","og_description":"Abdul Latif Jameel General Trading based in Tokyo, Japan, part of the diversified family business Abdul Latif Jameel, announced a new collaboration with Cellspect for the distribution of the Cellspect blood testing device in the Middle East, Africa, Southeast Asia and India. Cellspect, based in Japan, develops and produces next-generation PoCT (Point of Care Testing) [&hellip;]","og_url":"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/","og_site_name":"Abdul Latif Jameel","article_modified_time":"2024-10-25T08:09:07+00:00","og_image":[{"width":1235,"height":922,"url":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Cellspect-signing.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/","url":"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/","name":"Abdul Latif Jameel y Cellspect colaboran para llevar la pr\u00f3xima generaci\u00f3n de dispositivos port\u00e1tiles y de bajo coste para el an\u00e1lisis de la sangre en el punto de atenci\u00f3n a los mercados en desarrollo. - Abdul Latif Jameel","isPartOf":{"@id":"https:\/\/10.0.2.222\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/#primaryimage"},"image":{"@id":"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/#primaryimage"},"thumbnailUrl":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Cellspect-signing.jpg","datePublished":"2020-01-16T07:26:08+00:00","dateModified":"2024-10-25T08:09:07+00:00","breadcrumb":{"@id":"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/#primaryimage","url":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Cellspect-signing.jpg","contentUrl":"https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Cellspect-signing.jpg","width":1235,"height":922},{"@type":"BreadcrumbList","@id":"https:\/\/cms.alj3.clients.lemonhq.io\/es\/news\/abdul-latif-jameel-and-cellspect-collaborate-to-bring-next-generation-low-cost-portable-point-of-care-blood-testing-device-to-developing-markets-6\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/10.0.2.222\/en\/"},{"@type":"ListItem","position":2,"name":"Abdul Latif Jameel y Cellspect colaboran para llevar la pr\u00f3xima generaci\u00f3n de dispositivos port\u00e1tiles y de bajo coste para el an\u00e1lisis de la sangre en el punto de atenci\u00f3n a los mercados en desarrollo."}]},{"@type":"WebSite","@id":"https:\/\/10.0.2.222\/en\/#website","url":"https:\/\/10.0.2.222\/en\/","name":"Abdul Latif Jameel","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/10.0.2.222\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"post-meta-fields":{"_published_date":["field_6057129b493f5"],"published_date":["20191125"],"_location":["field_601267396ce72"],"location":["Tokio, Jap\u00f3n"],"_featured":["field_601a3b473c5c5"],"featured":[""],"_footnotes":["field_66fd39afb9383"],"footnotes":[""],"_business_sector":["field_66f6b5bcac8cb"],"business_sector":["Corporativa"],"_content_series":["field_66fe3c439f8f6"],"content_series":[""],"_old_post_id":["field_66fe3fd59f8f7"],"old_post_id":["57248"],"_short_title":["field_60925d67125ef"],"short_title":["Dispositivos de an\u00e1lisis de sangre para mercados emergentes"],"_summary":["field_6019304103a20"],"summary":["El objetivo es proporcionar an\u00e1lisis de sangre sencillos, precisos, asequibles y r\u00e1pidos a los pa\u00edses en desarrollo."],"_mobile_featured_image":["field_66f6b4bee65f3"],"mobile_featured_image":["https:\/\/media.alj3.clients.lemonhq.io\/wp-content\/uploads\/2024\/10\/Cellspect-signing.jpg"],"_push_notification":["field_66f6b47de65f1"],"push_notification":[""],"_publish_mobile":["field_66f6b491e65f2"],"publish_mobile":[""],"_status":["field_652694983fe12"],"status":["publish"],"_thumbnail_id":["3376"],"_wp_page_template":["default"],"_last_translation_edit_mode":["translation-editor"],"_oembed_a7510c6bb133b8a028df60f9778ba238":["<iframe title=\"Abdul Latif Jameel &amp;  Cellspect Announce Collaboration (EN 16:9)\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/RaydkfoEsPU?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>"],"_oembed_time_a7510c6bb133b8a028df60f9778ba238":["1729091457"],"select_category":["international"]},"_links":{"self":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/es\/wp-json\/wp\/v2\/pressrelease\/3395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/es\/wp-json\/wp\/v2\/pressrelease"}],"about":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/es\/wp-json\/wp\/v2\/types\/pressrelease"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.alj3.clients.lemonhq.io\/es\/wp-json\/wp\/v2\/media\/3376"}],"wp:attachment":[{"href":"https:\/\/cms.alj3.clients.lemonhq.io\/es\/wp-json\/wp\/v2\/media?parent=3395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}